Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment.

AAPS PharmSciTech
Nusrat ChowdhuryAnup Kundu

Abstract

The adverse side effects and toxicity caused by the non-targeted delivery of doxorubicin has emphasized the demand of emerging a targeted delivery system. The goal of this study is to enhance the delivery of doxorubicin by formulating an aptamer-labeled liposomal nanoparticle delivery system that will carry and deliver doxorubicin specifically into Her-2+ breast cancer cells. Twelve liposomal batches were prepared using different saturated (HSPC and DPPC) and unsaturated (POPC and DOPC) lipids by thin film hydration. The liposomes were characterized for their particle size, zeta potential, and drug encapsulation efficiency. The particles were also assessed for in vitro toxicity and DOX delivery into the breast cancer cells. The formulations, F1 through F12, had a small particle size of less than 200 nm and a high entrapment efficiency of about 88 ± 5%. The best formulation, F5, had a particle size of 101 ± 14nm, zeta potential of + 5.63 ± 0.46 mV, and entrapment efficiency of ≈ 93%. The cytotoxicity studies show that the DOX-loaded liposomal formulations are more effective in killing cancer cells than the free DOX in both MCF-7 and SKBR-3 cells. The uptake studies show a significant increase in the uptake of the aptamer-labeled...Continue Reading

References

Jun 23, 1998·The Journal of Biological Chemistry·O MeyerD Papahadjopoulos
Sep 6, 2001·Journal of Pharmaceutical Sciences·R B CampbellR M Straubinger
Dec 12, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·D N WaterhouseM B Bally
May 11, 2002·BMC Biotechnology·Jacques-Philippe ColletierDidier Fournier
Jun 30, 2009·Nucleic Acids Research·Regis MartyHeidar-Ali Tajmir-Riahi
Dec 18, 2009·Cardiology·Kanu ChatterjeeJoel S Karliner
Jan 15, 2010·Methods in Molecular Biology·Reto A Schwendener, Herbert Schott
May 31, 2011·Biochimie·Xiao-Xiang ZhangMark W Grinstaff
Aug 26, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ditte Krohn JensenCamilla Foged
Aug 7, 2013·Nanomedicine·Pranali P DeshpandeVladimir P Torchilin
Feb 14, 2015·International Journal of Nanomedicine·Giuseppina Bozzuto, Agnese Molinari
Oct 12, 2016·ACS Central Science·Jian YangAlexander Kros
Jan 31, 2017·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·David PowellAnup Kundu
Jan 25, 2018·International Journal of Molecular Sciences·Rejhana KolašinacAgnes Csiszár
Jan 31, 2018·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Syed A A Rizvi, Ayman M Saleh
Feb 2, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Narottam LamichhaneJaved Mahmood
Apr 14, 2018·Nature Communications·Daniel RosenblumDan Peer
Jul 17, 2018·Advanced Drug Delivery Reviews·Susanne K GolombekTwan Lammers
Sep 21, 2018·Journal of Nanobiotechnology·Jayanta Kumar PatraHan-Seung Shin
Nov 9, 2018·International Journal of Molecular Sciences·Jessica MarinelloGiovanni Capranico

❮ Previous
Next ❯

Citations

Jun 1, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mahsa ShahriariMona Alibolandi

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
scanning electron microscopy
fluorescence microscopy
flow cytometry

Software Mentioned

GraphPad prism
GraphPad

Related Concepts